Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls

人脑动脉瘤壁平滑肌细胞的表型调节

基本信息

  • 批准号:
    12671363
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

The growth and rupture mechanisms of cerebral aneurysms are still unknown. We used immunohistochemical methods to determine the role of phenotypically modulated smooth muscle cells (SMCs) in the growth and rupture of cerebral aneurysms. Materials and Methods : Aneurysmal wall specimens (N=58) were obtained at operation or autopsy, and 12 control cerebral arteries were obtained at autopsy. Semiserial sections were subjected to immunohistochemical staining with antibodies to α -smooth muscle actin (α -SMA), desmin, smooth muscle myosin heavy chain isoforms (SM1 , SM2 and SMemb), macrophages and basic transcription regulatory binding protein 2 (BTEB2) which regulates the induction of the gene for SMemb. In control cerebral arteries, SMCs in the media was strongly immunostained for α -SMA, desmin, SM1 and SM2 ; immunoreactivity for SMemb was faint. SMCs in both unruptured and ruptured aneurysmal walls showed no staining of desmin; the expression of α -SMA was well preserved, the expression of SMemb was increased in 30 % of unruptured aneurysms, although the expression of SM2 and SMemb was decreased in all ruptured aneurysms. The expression of BTEB2 was increased in macrophages and SMCs in the large to grant unruptured aneurysms: it was not seen in ruptured aneurysms exhibiting macrophage infiltration. Our study suggests that SMCs in aneurysmal walls are phenotypically different from the contractile type in the media of normal cerebral arteries. In some unruptured aneurysms, at least some SMCs are of the synthetic type. The up-regulation of BTEB2 in macrophages and SMCs appears to the related to aneurysmal growth. SMCs in ruptured aneurysms may have lost both phenotypes (contractyle and synthetic) before rupture.
脑动脉瘤的生长和破裂机制尚不清楚。我们用免疫组织化学方法来确定表型调制的平滑肌细胞(SMCs)在脑动脉瘤的生长和破裂中的作用。材料和方法:在手术或尸检时获得动脉瘤壁标本(N=58),并在尸检时获得12条对照脑动脉。用α -平滑肌肌动蛋白(α -SMA)、结蛋白、平滑肌肌球蛋白重链亚型(SM 1、SM 2和SMemb)、巨噬细胞和调节SMemb基因诱导的碱性转录调节结合蛋白2(BTEB 2)的抗体对半脑切片进行免疫组织化学染色。在对照脑动脉中,中膜SMC对α -SMA、结蛋白、SM 1和SM 2免疫染色强烈;对SMemb免疫反应微弱。未破裂动脉瘤和破裂动脉瘤平滑肌细胞均未见结蛋白表达,α -SMA表达保持良好,30%未破裂动脉瘤SMemb表达增强,而所有破裂动脉瘤SM 2和SMemb表达均降低。BTEB 2的表达在巨噬细胞和平滑肌细胞中增加,在大到未破裂的动脉瘤中:在破裂的动脉瘤中没有观察到巨噬细胞浸润。我们的研究表明,平滑肌细胞在血管壁的表型不同的收缩型在正常脑动脉中膜。在一些未破裂的动脉瘤中,至少有一些SMC是合成型的。BTEB 2在巨噬细胞和平滑肌细胞中的表达上调可能与细胞的生长有关。破裂动脉瘤中的SMC可能在破裂前失去了两种表型(收缩型和合成型)。

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
永廣信治: "部分血栓化巨大動脈瘤の増大機序と治療"Jpn J Neurosurg. 10. 10-17 (2001)
Shinji Nagahiro:“部分血栓形成的巨大动脉瘤的生长机制和治疗” Jpn J Neurosurg。 10. 10-17 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Matsubara: "Angiographic and clinic characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia"AJNR. 21. 1016-1020 (2000)
S.Matsubara:“遗传性出血性毛细血管扩张相关脑动静脉畸形患者的血管造影和临床特征”AJNR。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K. Satoh: "Endovascular treatment for cerebral stroke"SHIKOKU ACTA MEDICA. 56. 227-234 (2000)
K. Satoh:“脑中风的血管内治疗”四国医学学报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Nakajima,S.Nagahiro,T.Sano,J.Satomi,K.Satoh: "Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls"Acta Neuropathologica. 100. 475-480 (2000)
N.Nakajima,S.Nagahiro,T.Sano,J.Satomi,K.Satoh:“人脑动脉瘤壁平滑肌细胞的表型调节”神经病理学报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S. Matsubara: "Guiglielmi detachable coid emboliation for ruptured lower-midbasilar trunk aneurysms -a report of five cases -"Neuroradiology. 43. 884-90 (2001)
S. Matsubara:“Guiglielmi 可分离性结肠栓塞术治疗破裂的下中基底干动脉瘤 - 五例报告 -”神经放射学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGAHIRO Shinji其他文献

Cerebral Venous Thrombosis Caused by Congenital Thrombophilia in Japan
日本先天性血栓形成倾向引起的脑静脉血栓
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    OKAZAKI Toshiyuki;KANEMATSU Yasuhisa;SHIMADA Kenji;KORAI Masaaki;SATOMI Junichiro;UNO Masaaki;NAGAHIRO Shinji;TAKAGI Yasushi;Akihiro Shindo
  • 通讯作者:
    Akihiro Shindo

NAGAHIRO Shinji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGAHIRO Shinji', 18)}}的其他基金

Early diagnosis and pharmacological treatment to prevent the rupture of cerebral aneurysms
早期诊断和药物治疗预防脑动脉瘤破裂
  • 批准号:
    15H04950
  • 财政年份:
    2015
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms underlying the rupture of cerebral aneurysms and the pharmacological regulation
脑动脉瘤破裂的分子机制及药理调控
  • 批准号:
    24390344
  • 财政年份:
    2012
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
molecular mechanisms in the formation and rupture of cerebral aneurysm and impact of drug treatment
脑动脉瘤形成、破裂的分子机制及药物治疗的影响
  • 批准号:
    21390412
  • 财政年份:
    2009
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism of cerebral aneurysm formation in experimental model rats
实验模型大鼠脑动脉瘤形成机制
  • 批准号:
    17390401
  • 财政年份:
    2005
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Instability and remodeling of cerebral aneurysmal walls
脑动脉瘤壁的不稳定和重塑
  • 批准号:
    15591528
  • 财政年份:
    2003
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology
用于血管平滑肌细胞力学生物学和病理学的仿生血管基质
  • 批准号:
    10586599
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Obscurin-Deficient Breast Epithelia Generate Secreted Factors that Prime Lung Vascular Smooth Muscle Cell Pre-metastatic Microenvironment Formation
暗蛋白缺陷的乳腺上皮细胞产生分泌因子,促进肺血管平滑肌细胞转移前微环境的形成
  • 批准号:
    10749467
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
BRITE Relaunch: Examining the Role of Mechanotransduction in Smooth Muscle Cell Phenotype Modulation
BRITE 重新推出:检查机械转导在平滑肌细胞表型调节中的作用
  • 批准号:
    2422794
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Standard Grant
Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis
平滑肌细胞胰岛素抵抗和全身代谢功能障碍在动脉粥样硬化发展和晚期病变发病机制中的作用
  • 批准号:
    10731723
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
  • 批准号:
    10910432
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Investigation of a cause of smooth-muscle-cell massive cell death and intrinsic tissue collapse by time-lapse analysis of vascular-wall mechanical fields
通过血管壁机械场的延时分析研究平滑肌细胞大量细胞死亡和内在组织崩溃的原因
  • 批准号:
    23H03715
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
  • 批准号:
    10733477
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.
平滑肌细胞衍生的细胞命运和细胞相互作用在疾病进展和消退中动脉粥样硬化斑块的稳定性。
  • 批准号:
    10567844
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk
鉴定导致动脉粥样硬化斑块稳定性和心血管疾病风险的平滑肌细胞基因
  • 批准号:
    10720225
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis
靶向平滑肌细胞 BMAL1 作为抗再狭窄的新治疗策略
  • 批准号:
    10561398
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了